XNAS: PRLD
Prelude Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinica...
Read More
4.19
0.01
(0.24%)
113.6K
XNAS Volume
XNAS 17 Jul, 2026 3:14 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Prelude Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..